Quattro Advisors’s AbbVie ABBV Stock Holding History

Quattro Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	+872	New	+$188K	0.15%	55
2026 Q1	–	Sell	-807	Closed	-$184K	–	53
2025 Q4	$184K	Buy	+807	New	+$184K	0.15%	50

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quattro Advisors's ABBV Position: Q2 2026 in Review

Quattro Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 872 shares worth $219K. The stake represents 0.15% of the portfolio and ranks #55 among its holdings. This is a return to the name: Quattro Advisors previously reported a position in ABBV as recently as Q4 2025.

Quattro Advisors first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Quattro Advisors held 872 shares of AbbVie worth $219K as of Q2 2026.
AbbVie was a new Quattro Advisors position in Q2 2026.
AbbVie made up 0.15% of Quattro Advisors's portfolio in Q2 2026, its #55 holding.
Quattro Advisors first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Quattro Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.